Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specified Drug Use Results Survey of Vesicare Tablets

NCT01489709 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01489709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01489709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specified Drug Use Results Survey of Vesicare Tablets
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2011
Enrollment
1,160 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder